Chronic fluoxetine treatment reduces hypothalamic vasopressin secretion in vitro
- 16 October 1992
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 593 (2) , 311-313
- https://doi.org/10.1016/0006-8993(92)91326-a
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Abnormalities in the Regulation of Vasopressin and Corticotropin Releasing Factor Secretion in Obsessive-Compulsive DisorderArchives of General Psychiatry, 1992
- Colchicine-induced increases in immunoreactive neuropeptide levels in hypothalamus: Use as an index of biosynthesisLife Sciences, 1991
- Obsessive-Compulsive DisorderJournal of Clinical Psychopharmacology, 1990
- Effects of serotonergic agonists and antagonists on corticotropin-releasing hormone secretion by explanted rat hypothalamiPeptides, 1989
- Central serotonergic influences on renal electrolyte and water excretionNeuropharmacology, 1987
- Vasopressin peptide (DDAVP) may narrow the focus of attention in normal elderlyPsychiatry Research, 1986
- Neural regulation of the circadian vasopressin rhythm in cerebrospinal fluid: a pre-eminent role for the suprachiasmatic nucleiJournal of Neuroscience, 1985
- Chronic effects of fluoxetine, a selective inhibitor of serotonin uptake, on neurotransmitter receptorsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1985
- Effect of substances influencing brain serotonergic transmission on plasma vasopressin levels in the ratEuropean Journal of Pharmacology, 1985
- Behavioral effects of intracerebroventricularly administered neurohypophyseal hormone analogs in micePharmacology Biochemistry and Behavior, 1982